Alemtuzumab
Drug · tier A · 8 trials (3 recruiting) · 5 publications · score 54.0
Abatacept
Drug · tier A · 7 trials (2 recruiting) · 1 publications · score 44.0
Sirolimus
Drug · tier A · 8 trials (1 recruiting) · 0 publications · score 40.5
Tacrolimus Anhydrous
Drug · tier A · 8 trials (2 recruiting) · 0 publications · score 40.0
Angiotensin Ii
Drug · tier A · 2 trials (0 recruiting) · 0 publications · score 25.5
Research map, not treatment advice. Built 2026-10-07.